European Leukemia Trial Registry
Trial: ALL ProphyALL

More Details
Title Liposomales Amphotericin B in antifungal primary prophylaxis in ALL
Scientific Title ProphyALL - Pilot study on safety of four weekly administrations of 7 mg/kg of liposomal amphotericin B (AmBisome?) in antifungal primary prophylaxis treatment of elderly patients with acute lymphoblastic leukemia undergoing induction chemotherapy within the GMALL-Elderly protocol
Short Title ALL ProphyALL
Trialgroup GMALL
Type of Trial multicentric, single-group, open-label
Disease Miscellaneous(Miscellaneous) Supportive Care
Acute lymphoblastic leukemia(ALL) All subtypes
Age >=55 years
Status Closed
Start of Recruitment 01.05.2007
Leader Böhme, PD Dr. med., Angelika

General Contact Person
Müller, Dr., Monika
Tel: +49 (0)89 98 90 25
Fax: +49 (0)89 98 90 62

Centre of Trial Onkologikum Frankfurt am Museumsufer
Shortprotocol Shortprotocol
Remark Complementary study to the GMALL Elderly 01/2003 protocol
created 05.06.2007 Anja Hellenbrecht
changed 06.05.2008 Anja Hellenbrecht
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |